ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 1935 • 2015 ACR/ARHP Annual Meeting

    Regulation of T Follicular Helper Cells in Systemic Lupus Erythematosus By E3 Ubiquitin Ligase Cbl-b

    William Willis1, Yun Xiao2, Nicholas A. Young1, Wael N. Jarjour1 and Jian Zhang2, 1Immunology and Rheumatology, The Ohio State University Wexner Medical Center, Columbus, OH, 2Microbial Infection and Immunity, The Ohio State University Wexner Medical Center, Columbus, OH

    Background/Purpose: Activation of polyclonal CD4+ T cells and B cells is a hallmark of human and murine lupus, which suggests a global defect in the…
  • Abstract Number: 1936 • 2015 ACR/ARHP Annual Meeting

    STAT3-Regulated Gene Expression in Circulating CD4+ T Cells Discriminates RA Patients Independently of Clinical Parameters in Early Arthritis: A Validation Study

    Arthur G Pratt1, Amy E. Anderson1, Dennis W Lendrem2, Andrew Skelton2, Jonathan Massey3, Nisha Nair3, Julie Diboll2, Ben Hargreaves2, Philip M Brown2, Anne Barton4,5 and John D Isaacs2, 1Institute of Cellular Medicine (Musculoskeletal Research Group), National Institute for Health Research Newcastle Biomedical Research Centre based at Newcastle Hospitals Foundation Trust and Newcastle University, Newcastle upon Tyne, United Kingdom, 2Institute of Cellular Medicine (Musculoskeletal Research Group), NIHR Newcastle Biomedical Research Centre, Newcastle Hospitals Foundation Trust and Newcastle University, Newcastle upon Tyne, United Kingdom, 3NIHR Manchester Musculoskeletal Biomedical Research Unit, Manchester Academy of Health Sciences, Manchester, United Kingdom, 4NIHR Manchester Musculoskeletal Biomedical Research Unit, Manchester Academic Health Science Centre, Manchester, United Kingdom, 5Arthritis Research UK Centre for Genetics and Genomics, University of Manchester, Manchester, United Kingdom

    Background/Purpose:  A previously described transcriptional signature present in circulating CD4+ T cells of early rheumatoid arthritis (RA) patients implicated STAT3 signalling as an early pathophysiological…
  • Abstract Number: 1937 • 2015 ACR/ARHP Annual Meeting

    Dalazatide (ShK-186), a First-in-Class Blocker of Kv1.3 Potassium Channel on Effector Memory T Cells: Safety, Tolerability and Proof of Concept of Immunomodulation in Patients with Active Plaque Psoriasis

    Ernesto J. Munoz-Elias1, David Peckham1, Kayla Norton1, Judilyn Duculan2, Inna Cueto2, Xuan Li3, James Qin4, Kurt Lustig5, Eric Tarcha1, Jared Odegard4, James G. Krueger2 and Shawn P. Iadonato1, 1Kineta Inc, Seattle, WA, 2Rockefeller University, New York, NY, 3Rockefeller University, New York, WA, 4Benaroya Research Institute at Virginia Mason, Seattle, WA, 5Kineta Inc., Seattle, WA

    Background/Purpose: Effector memory T cells of both CD4 and CD8 lineages are key drivers of autoimmunity and are pathogenic in several autoimmune diseases including psoriasis,…
  • Abstract Number: 1938 • 2015 ACR/ARHP Annual Meeting

    Engaging PD-1 Resuscitates Synovial Treg Cells and Dampens the Joint Infiltrating T Cells in Rheumatoid Arthritis

    Dipendra Kumar Mitra1 and Kaustav Chowdhury2, 1Transplant Immunology & Immunogenetics, All India Institute of Medical Sciences, Delhi, India, 2TRANSPLANT IMMUNOLOGY AND IMMUNOGENETICS, ALL INDIA INSTITUTE OF MEDICAL SCIENCES, New Delhi, India

    Background/Purpose: Enrichment of regulatory T cells (Treg) has been reported in the synovial fluid (SF) of RA patients, although they fail to alleviate the joint…
  • Abstract Number: 1939 • 2015 ACR/ARHP Annual Meeting

    Anti-GM-CSF Treatment Promotes Synovial Monocyte-Derived Dendritic Cells and Increases Th17 Cells during Experimental Arthritis

    Debbie M. Roeleveld1, Peter M. van der Kraan1, Wim B. van den Berg1, Ian P. Wicks2 and Marije I. Koenders1, 1Experimental Rheumatology, Radboud university medical center, Nijmegen, Netherlands, 2Inflammation Division, Walter and Eliza Hall Institute of Medical Research, Parkville, Australia

    Background/Purpose: Monocyte-derived dendritic cells  (MoDCs) differentiate from monocytes under inflammatory conditions like RA, and are very potent in presenting antigen to T cells. GM-CSF-responsive MoDCs…
  • Abstract Number: 1940 • 2015 ACR/ARHP Annual Meeting

    A Circulating Reservoir of Pathogenic-like CD4+ T Cells Shares a Genetic and Phenotypic Signature with the Inflamed Synovial Micro-Environment

    Roberto Spreafico1,2, Maura Rossetti1,2, Jorg van Loosdregt1, Carol A. Wallace3, Margherita Massa4, Silvia Magni-Manzoni5, Marco Gattorno6, Alberto Martini7, Daniel Lovell8,9 and Salvatore Albani2,10, 1Sanford-Burnham Medical Research Institute, La Jolla, CA, 2SingHealth Translational Immunology and Inflammation Centre, Singapore Health Services Pte Ltd, Singapore, Singapore, 3Seattle Children’s Hospital and Research Institute, Seattle, WA, 4Lab Biotecnologie, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy, 5Pediatric Rheumatology, IRCCS Ospedale Pediatrico Bambino Gesù, Rome, Italy, 6Instituto Giannina Gaslini and University of Genova, Genova, Italy, 7Istituto G. Gaslini, Universita' di Genova, Genova, Italy, 8Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 9Rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 10Duke-National University of Singapore Graduate Medical School, Singapore, Singapore

    Background/Purpose: Systemic immunological processes are profoundly shaped by the micro-environments where antigen recognition occurs. Identifying molecular signatures distinctive of such processes is pivotal to understand…
  • Abstract Number: 1941 • 2015 ACR/ARHP Annual Meeting

    Senescent T-Cells Expedite RANKL-Dependent Bone Loss in Rheumatoid Arthritis

    Johannes Fessler1, Rusmir Husic2, Elisabeth Lerchbaum3, Verena Schwetz3, Claudia Stiegler3, Barbara Obermayer-Pietsch3, Winfried B. Graninger4 and Christian Dejaco5, 1Rheumatology and Immunology, Medical University Graz, Graz, Austria, 2Rheumatology, Medical University Graz, Graz, Austria, 3Division of Endocrinology and Metabolism, Medical University Graz, Graz, Austria, 4Internal Medicine/Rheumatology, Medical University Graz, Graz, Austria, 5Department of Rheumatology and Immunology, Medical University Graz, Graz, Austria

    Background/Purpose: To study the influence of senescent CD28-T-cells on systemic osteoporosis in rheumatoid arthritis (RA) and patients with primary osteoporosis. Methods: Prospective, cross-sectional study on…
  • Abstract Number: 1942 • 2015 ACR/ARHP Annual Meeting

    B Cell Depletion By Rituximab in Lymphocyte Subpopulations from Peripheral Blood in Patients with Rheumatoid Arthritis

    Leticia Merino-Meléndez1, Jorge López-López2, Irene Llorente1, Santos Castañeda3, Federico Herrera2, Teresa Velasco4, Lorena Vega5, Francisco Rodriguez5, Jose María Alvaro-Gracia3, Rosario Garcia-Vicuña6, Cecilia Muñoz-Calleja2 and Isidoro Gonzalez-Alvaro7, 1Rheumatology, H.U. La Princesa, Madrid, Spain, 2Immunology, Hospital Universitario de La Princesa, Madrid, Spain, 3Hospital Universitario de La Princesa. IIS La Princesa, Madrid, Spain, 4Rheumatology, H.U La Princesa, Madrid, Spain, 5H.U. La Princesa, Madrid, Spain, 6Rheumatology, Hospital Universitario de La Princesa. IIS La Princesa, Madrid, Spain, 7Hospital Univ. de La Princesa, IIS Princesa, Madrid, Spain

    Background/Purpose: Rheumatoid arthritis (RA) is a chronic disease that leads to inflammation of the joints and other tissues. Rituximab (Rtx) is a therapeutic monoclonal antibody…
  • Abstract Number: 1943 • 2015 ACR/ARHP Annual Meeting

    Potent and Selective Tyk2 Inhibitors Block Th1- and Th17- Mediated Immune Responses and Reduce Disease Progression in Rodent Models of Delayed-Type Hypersensitivity and Psoriasis

    Wenyan Miao1, Craig Masse1, Jeremy Greenwood2, Rosana Kapeller1 and William Westlin1, 1Nimbus Therapeutics, Cambridge, MA, 2Schrodinger Inc., New York, NY

    Background/Purpose: Tyk2 is a member of the JAK family kinases and is a key mediator of IL-12, IL-23, and type I interferon signaling. These cytokines…
  • Abstract Number: 1944 • 2015 ACR/ARHP Annual Meeting

    Dalazatide Modulates CD4+ Effector Memory T-Cell Activity of Patients with Granulomatosis with Polyangiitis in Vitro

    Lucas L. Lintermans1, Ernesto J. Muñoz-Elías2, Minke G. Huitema1, Elisabeth Brouwer1, Abraham Rutgers1, Coen A. Stegeman3, Peter Heeringa4 and Wayel H. Abdulahad1, 1Rheumatology and Clinical Immunology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands, 2Translational Immunology & Preclinical Development, Kineta, Inc., Seattle, WA, 3Nephrology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands, 4Pathology and Medical Biology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands

    Background/Purpose: There is substantial evidence that CD4+ effector memory T (TEM) cells play a crucial role in the pathogenesis of Granulomatosis with polyangiitis (GPA). The…
  • Abstract Number: 1945 • 2015 ACR/ARHP Annual Meeting

    microRNA-30a Promotes the Inflammatory Response of Rheumatoid Arthritis By Regulating Th1 Cell Differentiation

    Jing Zhang1, HUA YE2, Jianping Guo1, Yan Du3, Mengru Liu1 and Zhanguo Li4, 1Department of Rheumatology and Immunology, Peking University People's Hospital, Beijing, China, 2No.11 XIZHIMENG SOUTH STREET,, Peking University People's Hospital, Beijing, China, 3Department of Rheumatology and Immunology, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Zhejiang, China, 4Peking University People's Hospital, Beijing, China

    Background/Purpose:  In our previous study, the transcriptome profiles of CD4+T cells from 13 active RA cases and 9 healthy controls were accessed by microarrays. a…
  • Abstract Number: 1946 • 2015 ACR/ARHP Annual Meeting

    A Novel HLA-DRB1*10:01 Restricted T Cell Epitope from Citrullinated Type II Collagen Relevant for Rheumatoid Arthritis

    Karine Chemin1, Sabrina Pollastro2, Eddie James3, Changrong Ge4, Inka Albrecht5, Jessica Herrath6, Christina Gerstner7, Thais Rizzi2, Karolina Tandre8, Lars Rönnblom8, Anca I Catrina9, Rikard Holmdahl10, L. Klareskog11, Niek De Vries12 and Vivianne Malmström11, 1Medicine, Rheumatology Unit, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden, 2Department of Clinical Immunology and Rheumatology, Amsterdam, Netherlands, 3Benaroya Research Institute at Virginia Mason, Seattle, WA, 4Department of Medical Biochemistry and Biophysics, Medical Inflammation Research, Karolinska Institute, Stockholm, Sweden, 5Rheumatology Unit, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden, 6Department of Medicine,, Rheumatology Unit, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden, 7Department of Medicine, Rheumatology Unit, Karolinska University Hospital, Solna, Stockholm, Sweden, 8Section of Rheumatology, Department of Medical Sciences, Uppsala University, Uppsala, Sweden, 9Unit of Rheumatology, Department of Medicine Solna, Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden, 10Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden, 11Rheumatology Unit, Department of Medicine, Karolinska Institutet, Stockholm, Sweden, 12Dept. of Clinical Immunology & Rheumatology, Amsterdam Rheumatology and immunology Center, Academic Medical Center/University of Amsterdam, Amsterdam, Netherlands

    Background/Purpose: Antibodies against citrullinated collagen type II (Cit-CII) are common in sera and synovial fluids of Rheumatoid Arthritis (RA) patients, whereas the known CII T-cell…
  • Abstract Number: 1947 • 2015 ACR/ARHP Annual Meeting

    Hypermethylation of Treg-Specific Demethylated Regions in the Ikaros Transcription Factor Family Members, Helios and Eos, in Rheumatoid Arthritis Tregs

    Alla Skapenko1, Viktoria Soentgerath1, Sonja Haupt2, Jan Leipe1 and Hendrik Schulze-Koops1, 1Division of Rheumatology and Clinical Immunology, University of Munich, Munich, Germany, 2Division of Rheumatology and Clinical Immunology, Med.Klinik und Poliklinik IV, University of Munich, Munich, Germany

    Background/Purpose: Foxp3 is the signature transcription factor of regulatory T cells (Tregs) and facilitates many of the characteristic functions of Tregs. Members of the Ikaros…
  • Abstract Number: 1948 • 2015 ACR/ARHP Annual Meeting

    Early Rheumatoid Arthritis Patients Have Higher Fractions of Circulating Th2 Cells, Th17 Cells and Regulatory T Cells, Similar Fractions of Follicular Helper T Cells, and Lower Fractions of Th17/Th1 Cells and Th1 Cells Compared to Healthy Controls

    Jayesh Pandya, Magnus Hallström, Kerstin Andersson, Inger Nordström, Anna-Carin Lundell and Anna Rudin, Dept of Rheumatology and Inflammation Research, The Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden

    Background/Purpose: A comprehensive analysis of the circulating T cell subtype pattern, including T helper 1 (Th1) cells, Th2 cells, Th17 cells, Th1/Th17 cells, T follicular…
  • Abstract Number: 1949 • 2015 ACR/ARHP Annual Meeting

    Generation and Immunophenotyping of Citrullin-Specific T Cell Lines from Peripheral Blood and Synovial Fluid of ACPA+ RA Patients

    Muhammad Sohel Mia1, Christina Gerstner1, Daniel Ramsköld1, Jessica Herrath2, Anatoly Dubnovitsky1,3, Marline Marline4, Annika van Vollenhoven1, Qiaolin Deng4, Adnane Achour3 and Vivianne Malmström5, 1Department of Medicine, Rheumatology Unit, Karolinska University Hospital, Solna, Stockholm, Sweden, 2Department of Medicine,, Rheumatology Unit, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden, 3Department of Medicine, Science for Life Laboraories, Karolinska Institute, Stockholm, Sweden, 4Cell and Molecular Biology Department, Ludwig Institute for Cancer Research, Karolinska Institute, Solna, Stockholm, Sweden, 5Rheumatology Unit, Department of Medicine, Karolinska Institutet, Stockholm, Sweden

    Background/Purpose: Citrulline autoimmunity is a characteristic of ACPA+ Rheumatoid Arthritis (RA). Many autoantigens have been implicated even within patients of the same HLA such as…
  • « Previous Page
  • 1
  • …
  • 1816
  • 1817
  • 1818
  • 1819
  • 1820
  • …
  • 2425
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology